Chemomab Therapeutics, Ltd., (Nasdaq: CMMB), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that ...

The Middle Eastern Alliance for Parenteral and Enteral Nutrition (MEAPEN) Congress returns for its 4th edition later this month, bringing together an extensive network of healthcare professionals in ...

Alfred University students enrolled in a class on battery machine learning participated in a poster session Thursday, April 17, as part of ...

Around 300 students participated in the annual Jay W. Boland Research Day at East Tennessee State University, an event ...

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will attend the ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) 74th Annual Scientific Session and Expo in Chicago, March 29-31.

The company’s participation highlights its continued leadership in the development of non-lens-based solutions for aging-related vision loss. Event at ASCRS 2025 Los Angeles: Take the Presbyopia ...

Each year, the Drake Undergraduate Science Collaborative Institute hosts the Drake University Conference on Undergraduate ...

RIT's scientific photography degree immerses you in the fascinating world of scientific photography, where you’ll use photography to capture images and collect scientific data. Photographic sciences ...

Three epilepsy posters to be presented in scientific sessions at the American Academy of Neurology meetingLong-term 36-month data from the ...

Presented by Sho Takemoto, Massachusetts General Hospital. Poster Session 1. Pharmacy, Sunday, April 27, 6:00 – 7:00 p.m. ET: 803 – Developing Models for New Drugs in PAH: A Pharmacokinetic ...

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based ...